Solutions
Indian biotech & pharma sponsors
Own your trial data, end to end — under DPDP Act 2023, with Indian-jurisdiction contracting.
Aligned to the DPDP Act 2023 by default.
DPDP-compliant consent and processing flows.
Submission-ready exports for CDSCO, and CDISC SDTM for international filings.
DPDP Act 2023
Aligned by design
Schedule Y
CDSCO-aligned by design
ISO 27001
Information security controls aligned
Other ways teams use Trialion
Bioequivalence (BA-BE) specialists
Built-in PK sampling schedules, replicate-design support, and ANDA-ready exports — for the segment where India leads global study volume.
Learn moreGeneric-drug CROs
Short, focused trials at scale — pricing and tooling aligned to how generic-drug development actually operates in India.
Learn moreMulti-therapy CROs
Phase II to IV across therapeutic areas — same data model, configurable workflows, one continuous audit trail.
Learn more